The dual role of small EVs in asthma and chronic obstructive pulmonary disease: from pathogenesis to clinical translation
- 1ard II, Department of Respiratory and Critical Care Medicine, Liuzhou Traditional Chinese Medical Hospital (Liuzhou Zhuang Medical Hospital), Liuzhou, Guangxi, China
Abstract
Asthma and chronic obstructive pulmonary disease (COPD) are leading causes of chronic respiratory morbidity, yet current therapies fail to halt airway remodeling or disease progression. Small extracellular vesicles (small EVs), a nanoscale subset of extracellular vesicles that includes exosomes, have emerged as key mediators of intercellular communication in the lung, transferring proteins, lipids and nucleic acids to modulate inflammation, immunity and tissue repair. Their cargo reflects donor cell state and can be sampled from biofluids, suggesting their potential as liquid-biopsy biomarkers and therapeutic vehicles. Notably, small EVs exert context-dependent bidirectional effects in asthma and COPD, either exacerbating airway inflammation and remodeling or suppressing immune responses and promoting repair. This review synthesizes the biological functions of small EVs in these diseases, dissects mechanisms underlying their dual roles, and evaluates their translational potential as biomarkers and candidate therapeutic strategies, while outlining critical challenges in isolation, standardization and clinical validation.
Related
- Ginsenoside Rg1 Alleviates Chronic Obstructive Pulmonary Disease Partially Through Regulating ABCB1-Mediated Mitochondrial Dysfunction.
- Single-Cell Transcriptomic Analysis Identifies a Translation/RBP-Related Fibroblast Signature for Drug Repurposing in Idiopathic Pulmonary Fibrosis
- Gene therapy for non-obstructive azoospermia: therapeutic avenues and translational pathway to clinical application
- Flow Cytometry and AI-Driven Biomarker Discovery in Acute Kidney Injury: From Mechanistic Insights to Translation Applications in Clinical and Austere Environments
- Targeted protein degradation: bridging chemical biology and clinical translation
BibTeX
@article{li2026dual,
title = {{The dual role of small EVs in asthma and chronic obstructive pulmonary disease: from pathogenesis to clinical translation}},
author = {Jun Li and Zhouqiang Li and Haining Hu and Guanzhu Wu and Ye Peng and Hualing Zhang},
journal = {Frontiers in Medicine},
year = {2026},
month = nov,
doi = {10.3389/fmed.2026.2011703},
url = {https://doi.org/10.3389/fmed.2026.2011703},
note = {CC BY},
}
RIS
TY - JOUR
TI - The dual role of small EVs in asthma and chronic obstructive pulmonary disease: from pathogenesis to clinical translation
AU - Jun Li
AU - Zhouqiang Li
AU - Haining Hu
AU - Guanzhu Wu
AU - Ye Peng
AU - Hualing Zhang
PY - 2026
DA - 2026/11/02
JO - Frontiers in Medicine
DO - 10.3389/fmed.2026.2011703
UR - https://doi.org/10.3389/fmed.2026.2011703
AB - Asthma and chronic obstructive pulmonary disease (COPD) are leading causes of chronic respiratory morbidity, yet current therapies fail to halt airway remodeling or disease progression. Small extracellular vesicles (small EVs), a nanoscale subset of extracellular vesicles that includes exosomes, have emerged as key mediators of intercellular communication in the lung, transferring proteins, lipids and nucleic acids to modulate inflammation, immunity and tissue repair. Their cargo reflects donor cell state and can be sampled from biofluids, suggesting their potential as liquid-biopsy biomarkers and therapeutic vehicles. Notably, small EVs exert context-dependent bidirectional effects in asthma and COPD, either exacerbating airway inflammation and remodeling or suppressing immune responses and promoting repair. This review synthesizes the biological functions of small EVs in these diseases, dissects mechanisms underlying their dual roles, and evaluates their translational potential as biomarkers and candidate therapeutic strategies, while outlining critical challenges in isolation, standardization and clinical validation.
SN - 2296-858X
ER -